Archive · 28 Sep 2026
Glucosamine Study Raises Questions About Alzheimer’s Progression Risks
A new study looked at whether glucosamine, a supplement used for joint pain, might be connected to brain health.
The researchers found that people with mild cognitive impairment who used it had a higher risk of developing dementia.
They also found a higher mortality risk among some people with dementia who used glucosamine.
However, the study only found an association.
It did not prove that glucosamine caused dementia or made it progress faster.
Scientists have some possible explanations from laboratory and animal studies, but these ideas have not been confirmed in humans.
Doctors say people should not stop taking glucosamine without medical advice.
Anyone with memory problems should tell their doctor about all supplements they use.
A large health-record analysis linked glucosamine use to a 25% higher risk of mild cognitive impairment progressing to dementia.
Researchers also reported higher mortality risk among people with dementia who used glucosamine.
Laboratory and animal research suggests glucosamine may affect sugar-related protein processes involved in neurodegeneration.
Experts stress that the study was observational and does not prove glucosamine causes Alzheimer’s disease or dementia progression.
Doctors advise patients not to stop glucosamine abruptly and to discuss supplement use with their healthcare providers.
- Who
- Researchers examined glucosamine users, including people with mild cognitive impairment or dementia, and doctors including Dr Nupur Rajoriya, Dr Anandh Balasubramaniam, and Dr Sai Kumar commented on the findings.
- What
- A health-record study found that glucosamine use was associated with a 25% higher risk of mild cognitive impairment progressing to dementia, while experts emphasized that this does not prove causation.
- When
- The report describes the research as a new study, but does not specify when the data were collected or published.
- Where
- The analysis used retrospective healthcare data from a United States healthcare system; the article also discusses implications for patients in India.
- Why
- The study was intended to examine a possible relationship between glucosamine use and cognitive decline, prompting further questions about how the supplement may affect brain biology.
Concern About Possible Brain Effects
Caution Against Concluding Harm
Meaning of the findings
Concern About Possible Brain Effects
The association with faster dementia progression, higher mortality risk, and findings from laboratory and animal research raise concerns that glucosamine could affect brain health.
Caution Against Concluding Harm
Doctors say the evidence comes from an observational study and may reflect confounding factors, so it does not establish that glucosamine causes Alzheimer’s disease or accelerates dementia.
What patients should do
Concern About Possible Brain Effects
People with memory concerns may need to evaluate supplement use carefully with their healthcare providers.
Caution Against Concluding Harm
Patients should not stop glucosamine on their own; decisions should consider its purpose, perceived benefit, and overall neurological health.
- Supplement studied
- Glucosamine, commonly used for joint pain and osteoarthritis
- Reported association
- A 25% increased risk of mild cognitive impairment progressing to dementia among glucosamine users
- Additional finding
- Higher mortality risk was reported among people already diagnosed with dementia who used glucosamine
- Study type
- Retrospective analysis of healthcare records; observational rather than a clinical trial
- Possible mechanism
- Researchers are investigating whether glucosamine affects glycosylation, or sugar-related protein modification
- Expert advice
- Do not discontinue glucosamine abruptly; discuss its use with a physician
- Research need
- Clinical trials and further human research are needed to determine whether glucosamine has any direct harmful effect